{
  "name": "Overview of Adverse Events",
  "id": "FDA-AE-T06",
  "mainListOfContents": {
    "name": "List of Planned Analyses",
    "label": "LOPA",
    "contentsList": {
      "listItems": [
        {
          "name": "Overview of Adverse Events",
          "level": 1,
          "order": 1,
          "outputId": "Out_04",
          "sublist": {
            "listItems": [
              {
                "name": "    Summary of Subjects by Treatment",
                "level": 2,
                "order": 1,
                "analysisId": "An_30"
              },
              {
                "name": "    SAE [3]",
                "level": 2,
                "order": 2,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with any SAE by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_31"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_32"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_32_1"
                    }
                  ]
                }
              },
              {
                "name": "        Results in Death",
                "level": 2,
                "order": 3,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with any SAE that Results in Death by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_33"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that Results in Death, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_34"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that Results in Death, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_34_1"
                    }
                  ]
                }
              },
              {
                "name": "        Is Life Threatening",
                "level": 2,
                "order": 4,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with any SAE that Is Life Threatening by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_35"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that Is Life Threatening, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_36"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that Is Life Threatening, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_36_1"
                    }
                  ]
                }
              },
              {
                "name": "        Requires or Prolongs Hospitalization",
                "level": 2,
                "order": 5,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with any SAE that Requires or Prolongs Hospitalization by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_37"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that Requires or Prolongs Hospitalization, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_38"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that Requires or Prolongs Hospitalization, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_38_1"
                    }
                  ]
                }
              },
              {
                "name": "        Persist or Significant Disability / Incapacity",
                "level": 2,
                "order": 6,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with any SAE that Persist or Significant Disability / Incapacity by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_39"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that involves Persist or Significant Disability / Incapacity, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_40"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that involves Persist or Significant Disability / Incapacity, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_40_1"
                    }
                  ]
                }
              },
              {
                "name": "        Congenital Anomaly or Birth Defect",
                "level": 2,
                "order": 7,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with any SAE that involves Congenital Anomaly or Birth Defect by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_41"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that involves Congenital Anomaly or Birth Defect, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_42"
                    },
                    {
                      "name": "        Comparison of subjects with any SAE that involves Congenital Anomaly or Birth Defect, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_42_1"
                    }
                  ]
                }
              },
              {
                "name": "        Other",
                "level": 2,
                "order": 8,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with any Other SAE by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_43"
                    },
                    {
                      "name": "        Comparison of subjects with any Other SAE, Xanomeline Low Dose vs Placebo ",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_44"
                    },
                    {
                      "name": "        Comparison of subjects with any Other SAE, Xanomeline High Dose vs Placebo ",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_44_1"
                    }
                  ]
                }
              },
              {
                "name": "    AE leading to permanent discontinuation of study drug",
                "level": 2,
                "order": 9,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with AE leading to permanent discontinuation of study drug, by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_45"
                    },
                    {
                      "name": "        Comparison of subjects with AE leading to permanent discontinuation of study drug, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_46"
                    },
                    {
                      "name": "        Comparison of subjects with AE leading to permanent discontinuation of study drug, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_46_1"
                    }
                  ]
                }
              },
              {
                "name": "    AE leading to dose modification of study drug",
                "level": 2,
                "order": 10,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with AE leading to dose modification of study drug, by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_47"
                    },
                    {
                      "name": "        Comparison of subjects with AE leading to dose modification of study drug, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_48"
                    },
                    {
                      "name": "        Comparison of subjects with AE leading to dose modification of study drug, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_48_1",
                      "sublist": {
                        "listItems": [
                          {
                            "name": "            Summary of subjects with AE leading to dose modification of study drug, by Treatment and Action Taken",
                            "level": 4,
                            "order": 1,
                            "analysisId": "An_47_1"
                          },
                          {
                            "name": "            Comparison of subjects with AE leading to dose modification of study drug by Action Taken, Xanomeline Low Dose vs Placebo",
                            "level": 4,
                            "order": 2,
                            "analysisId": "An_48_2"
                          },
                          {
                            "name": "            Comparison of subjects with AE leading to dose modification of study drug by Action Taken, Xanomeline High Dose vs Placebo",
                            "level": 4,
                            "order": 3,
                            "analysisId": "An_48_3"
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              {
                "name": "    Any AE [4]",
                "level": 2,
                "order": 11,
                "sublist": {
                  "listItems": [
                    {
                      "name": "        Summary of subjects with Any AE by Treatment",
                      "level": 3,
                      "order": 1,
                      "analysisId": "An_49"
                    },
                    {
                      "name": "        Comparison of subjects with Any AE, Xanomeline Low Dose vs Placebo",
                      "level": 3,
                      "order": 2,
                      "analysisId": "An_50"
                    },
                    {
                      "name": "        Comparison of subjects with Any AE, Xanomeline High Dose vs Placebo",
                      "level": 3,
                      "order": 3,
                      "analysisId": "An_50_1",
                      "sublist": {
                        "listItems": [
                          {
                            "name": "            Summary of subjects with Any AE by Treatment and Severity/Intensity",
                            "level": 4,
                            "order": 1,
                            "analysisId": "An_49_1"
                          },
                          {
                            "name": "            Comparison of subjects with Any AE by Severity/Intensity, Xanomeline Low Dose vs Placebo",
                            "level": 4,
                            "order": 2,
                            "analysisId": "An_50_2"
                          },
                          {
                            "name": "            Comparison of subjects with Any AE by Severity/Intensity, Xanomeline High Dose vs Placebo",
                            "level": 4,
                            "order": 3,
                            "analysisId": "An_50_3"
                          }
                        ]
                      }
                    }
                  ]
                }
              }
            ]
          }
        }
      ]
    }
  },
  "version": 1,
  "otherListsOfContents": [
    {
      "name": "List of Planned Outputs",
      "label": "LOPO",
      "contentsList": {
        "listItems": [
          {
            "name": "Overview of Adverse Events",
            "level": 1,
            "order": 1,
            "outputId": "Out_04"
          }
        ]
      }
    }
  ],
  "terminologyExtensions": [
    {
      "id": "TermEx01",
      "sponsorTerms": [
        {
          "id": "TermEx01_01",
          "submissionValue": "POPULATION SUMMARY",
          "description": "Summary statistics describing the study population(s)."
        }
      ],
      "enumeration": "AnalysisPurposeEnum"
    }
  ],
  "analysisOutputCategorizations": [
    {
      "id": "ANSET",
      "categories": [
        {
          "id": "ANSET_01",
          "label": "Safety",
          "subCategorizations": [
            {
              "id": "ANSET_01_ANINT",
              "categories": [
                {
                  "id": "ANSET_01_ANINT_05",
                  "label": "Adverse Events"
                }
              ],
              "label": "Safety Analysis Of Interest"
            }
          ]
        }
      ],
      "label": "Analysis Sets"
    }
  ],
  "analysisSets": [
    {
      "name": "Safety Population",
      "description": "All patients randomized and known to have taken at least one dose of randomized drug.",
      "id": "AnalysisSet_01",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADSL",
        "variable": "SAFFL",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    }
  ],
  "dataSubsets": [
    {
      "name": "Any SAE",
      "label": "SAE [3]",
      "id": "Dss_07",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESER",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that Results in Death",
      "label": "    Results in Death",
      "id": "Dss_08",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESDTH",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that Is Life Threatening",
      "label": "    Is Life Threatening",
      "id": "Dss_09",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESLIFE",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that Requires or Prolongs Hospitalization",
      "label": "    Requires or Prolongs Hospitalization",
      "id": "Dss_10",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESHOSP",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that involves Persist or Significant Disability / Incapacity",
      "label": "    Persist or Significant Disability / Incapacity",
      "id": "Dss_11",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESDISAB",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "SAE that involves Congenital Anomaly or Birth Defect",
      "label": "    Congenital Anomaly or Birth Defect",
      "id": "Dss_12",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESCONG",
        "comparator": "EQ",
        "value": [
          "Y"
        ]
      }
    },
    {
      "name": "Other SAE",
      "label": "    Other [4]",
      "id": "Dss_13",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "OR",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESMIE",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESCAN",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 3,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESOD",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "AE leading to permanent discontinuation of study drug",
      "label": "AE leading to permanent discontinuation of study drug",
      "id": "Dss_14",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AEACN",
        "comparator": "EQ",
        "value": [
          "DRUG WITHDRAWN"
        ]
      }
    },
    {
      "name": "Any SAE, Xanomeline Low Dose or Placebo",
      "label": "SAE [3]",
      "id": "Dss_51",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESER",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "Any SAE, Xanomeline High Dose or Placebo",
      "label": "SAE [3]",
      "id": "Dss_52",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESER",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that Results in Death, Xanomeline Low Dose or Placebo",
      "label": "    Results in Death",
      "id": "Dss_53",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESDTH",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that Results in Death, Xanomeline High Dose or Placebo",
      "label": "    Results in Death",
      "id": "Dss_54",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESDTH",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that Is Life Threatening, Xanomeline Low Dose or Placebo",
      "label": "    Is Life Threatening",
      "id": "Dss_55",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESLIFE",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that Is Life Threatening, Xanomeline High Dose or Placebo",
      "label": "    Is Life Threatening",
      "id": "Dss_56",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESLIFE",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that Requires or Prolongs Hospitalization, Xanomeline Low Dose or Placebo",
      "label": "    Requires or Prolongs Hospitalization",
      "id": "Dss_57",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESHOSP",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that Requires or Prolongs Hospitalization, Xanomeline High Dose or Placebo",
      "label": "    Requires or Prolongs Hospitalization",
      "id": "Dss_58",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESHOSP",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that involves Persist or Significant Disability / Incapacity, Xanomeline Low Dose or Placebo",
      "label": "    Persist or Significant Disability / Incapacity",
      "id": "Dss_59",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESDISAB",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that involves Persist or Significant Disability / Incapacity, Xanomeline High Dose or Placebo",
      "label": "    Persist or Significant Disability / Incapacity",
      "id": "Dss_60",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESDISAB",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that involves Congenital Anomaly or Birth Defect, Xanomeline Low Dose or Placebo",
      "label": "    Congenital Anomaly or Birth Defect",
      "id": "Dss_61",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESCONG",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "SAE that involves Congenital Anomaly or Birth Defect, Xanomeline High Dose or Placebo",
      "label": "    Congenital Anomaly or Birth Defect",
      "id": "Dss_62",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESCONG",
              "comparator": "EQ",
              "value": [
                "Y"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "Other SAE, Xanomeline Low Dose or Placebo",
      "label": "    Other [4]",
      "id": "Dss_63",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "compoundExpression": {
              "logicalOperator": "OR",
              "whereClauses": [
                {
                  "level": 3,
                  "order": 1,
                  "condition": {
                    "dataset": "ADAE",
                    "variable": "AESMIE",
                    "comparator": "EQ",
                    "value": [
                      "Y"
                    ]
                  }
                },
                {
                  "level": 3,
                  "order": 2,
                  "condition": {
                    "dataset": "ADAE",
                    "variable": "AESCAN",
                    "comparator": "EQ",
                    "value": [
                      "Y"
                    ]
                  }
                },
                {
                  "level": 3,
                  "order": 3,
                  "condition": {
                    "dataset": "ADAE",
                    "variable": "AESOD",
                    "comparator": "EQ",
                    "value": [
                      "Y"
                    ]
                  }
                }
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "Other SAE, Xanomeline High Dose or Placebo",
      "label": "    Other [4]",
      "id": "Dss_64",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "compoundExpression": {
              "logicalOperator": "OR",
              "whereClauses": [
                {
                  "level": 3,
                  "order": 1,
                  "condition": {
                    "dataset": "ADAE",
                    "variable": "AESMIE",
                    "comparator": "EQ",
                    "value": [
                      "Y"
                    ]
                  }
                },
                {
                  "level": 3,
                  "order": 2,
                  "condition": {
                    "dataset": "ADAE",
                    "variable": "AESCAN",
                    "comparator": "EQ",
                    "value": [
                      "Y"
                    ]
                  }
                },
                {
                  "level": 3,
                  "order": 3,
                  "condition": {
                    "dataset": "ADAE",
                    "variable": "AESOD",
                    "comparator": "EQ",
                    "value": [
                      "Y"
                    ]
                  }
                }
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "AE leading to permanent discontinuation of study drug, Xanomeline Low Dose or Placebo",
      "label": "AE leading to permanent discontinuation of study drug",
      "id": "Dss_65",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AEACN",
              "comparator": "EQ",
              "value": [
                "DRUG WITHDRAWN"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "AE leading to permanent discontinuation of study drug, Xanomeline High Dose or Placebo",
      "label": "AE leading to permanent discontinuation of study drug",
      "id": "Dss_66",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AEACN",
              "comparator": "EQ",
              "value": [
                "DRUG WITHDRAWN"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "AE leading to dose modification of study drug",
      "label": "AE leading to dose modification of study drug",
      "id": "Dss_67",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AEACN",
        "comparator": "NOTIN",
        "value": [
          "NOT APPLICABLE",
          "DOSE NOT CHANGED"
        ]
      }
    },
    {
      "name": "AE leading to dose modification of study drug, Xanomeline Low Dose or Placebo",
      "label": "AE leading to dose modification of study drug",
      "id": "Dss_68",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AEACN",
              "comparator": "NOTIN",
              "value": [
                "NOT APPLICABLE",
                "DOSE NOT CHANGED"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "AE leading to dose modification of study drug, Xanomeline High Dose or Placebo",
      "label": "AE leading to dose modification of study drug",
      "id": "Dss_69",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AEACN",
              "comparator": "NOTIN",
              "value": [
                "NOT APPLICABLE",
                "DOSE NOT CHANGED"
              ]
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "Any AE",
      "label": "Any AE [5]",
      "id": "Dss_70",
      "level": 1,
      "order": 1,
      "condition": {
        "dataset": "ADAE",
        "variable": "AESEV",
        "comparator": "NE"
      }
    },
    {
      "name": "Any AE, Xanomeline Low Dose or Placebo",
      "label": "Any AE [5]",
      "id": "Dss_71",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESEV",
              "comparator": "NE"
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "1",
                "3"
              ]
            }
          }
        ]
      }
    },
    {
      "name": "Any AE, Xanomeline High Dose or Placebo",
      "label": "Any AE [5]",
      "id": "Dss_72",
      "level": 1,
      "order": 1,
      "compoundExpression": {
        "logicalOperator": "AND",
        "whereClauses": [
          {
            "level": 2,
            "order": 1,
            "condition": {
              "dataset": "ADAE",
              "variable": "AESEV",
              "comparator": "NE"
            }
          },
          {
            "level": 2,
            "order": 2,
            "condition": {
              "dataset": "ADAE",
              "variable": "TRTAN",
              "comparator": "IN",
              "value": [
                "2",
                "3"
              ]
            }
          }
        ]
      }
    }
  ],
  "analysisGroupings": [
    {
      "name": "Treatment",
      "id": "AnlsGrouping_16_Trt01An",
      "dataDriven": false,
      "groupingDataset": "ADSL",
      "groupingVariable": "TRT01AN",
      "groups": [
        {
          "name": "Xanomeline Low Dose \n(N=XX)\nn (%)",
          "id": "AnlsGrouping_16_Trt01An_01",
          "level": 1,
          "order": 1,
          "condition": {
            "dataset": "ADSL",
            "variable": "TRT01AN",
            "comparator": "EQ",
            "value": [
              "1"
            ]
          }
        },
        {
          "name": "Xanomeline High Dose \n(N=XX)\nn (%)",
          "id": "AnlsGrouping_16_Trt01An_02",
          "level": 1,
          "order": 2,
          "condition": {
            "dataset": "ADSL",
            "variable": "TRT01AN",
            "comparator": "EQ",
            "value": [
              "2"
            ]
          }
        },
        {
          "name": "Placebo \n(N=XX)\nn (%)",
          "id": "AnlsGrouping_16_Trt01An_03",
          "level": 1,
          "order": 3,
          "condition": {
            "dataset": "ADSL",
            "variable": "TRT01AN",
            "comparator": "EQ",
            "value": [
              "3"
            ]
          }
        }
      ]
    },
    {
      "name": "Action Taken with Study Treatment",
      "label": "AE leading to dose modification of study drug",
      "id": "AnlsGrouping_24_Aeacn",
      "dataDriven": false,
      "groupingDataset": "ADAE",
      "groupingVariable": "AEACN",
      "groups": [
        {
          "name": "AE leading to interruption of study drug",
          "label": "AE leading to interruption of study drug",
          "id": "AnlsGrouping_24_Aeacn_01",
          "level": 1,
          "order": 1,
          "condition": {
            "dataset": "ADAE",
            "variable": "AEACN",
            "comparator": "EQ",
            "value": [
              "DRUG INTERRUPTED"
            ]
          }
        },
        {
          "name": "AE leading to reduction of study drug",
          "label": "AE leading to reduction of study drug",
          "id": "AnlsGrouping_24_Aeacn_02",
          "level": 1,
          "order": 2,
          "condition": {
            "dataset": "ADAE",
            "variable": "AEACN",
            "comparator": "EQ",
            "value": [
              "DOSE REDUCED"
            ]
          }
        },
        {
          "name": "AE leading to dose delay of study drug",
          "label": "AE leading to dose delay of study drug",
          "id": "AnlsGrouping_24_Aeacn_03",
          "level": 1,
          "order": 3,
          "condition": {
            "dataset": "ADAE",
            "variable": "AEACN",
            "comparator": "EQ",
            "value": [
              "DOSE DELAY"
            ]
          }
        },
        {
          "name": "Other",
          "label": "Other",
          "id": "AnlsGrouping_24_Aeacn_04",
          "level": 1,
          "order": 4,
          "condition": {
            "dataset": "ADAE",
            "variable": "AEACN",
            "comparator": "EQ",
            "value": [
              "OTHER"
            ]
          }
        }
      ]
    },
    {
      "name": "Severity/Intensity",
      "label": "Any AE [4]",
      "id": "AnlsGrouping_25_Aesev",
      "dataDriven": false,
      "groupingDataset": "ADAE",
      "groupingVariable": "AESEV",
      "groups": [
        {
          "name": "Severe",
          "label": "Severe",
          "id": "AnlsGrouping_25_Aesev_01",
          "level": 1,
          "order": 1,
          "condition": {
            "dataset": "ADAE",
            "variable": "AESEV",
            "comparator": "EQ",
            "value": [
              "SEVERE"
            ]
          }
        },
        {
          "name": "Moderate",
          "label": "Moderate",
          "id": "AnlsGrouping_25_Aesev_02",
          "level": 1,
          "order": 2,
          "condition": {
            "dataset": "ADAE",
            "variable": "AESEV",
            "comparator": "EQ",
            "value": [
              "MODERATE"
            ]
          }
        },
        {
          "name": "Mild",
          "label": "Mild",
          "id": "AnlsGrouping_25_Aesev_03",
          "level": 1,
          "order": 3,
          "condition": {
            "dataset": "ADAE",
            "variable": "AESEV",
            "comparator": "EQ",
            "value": [
              "MILD"
            ]
          }
        }
      ]
    }
  ],
  "methods": [
    {
      "name": "bigN",
      "description": "Grouped summary of categorical variable",
      "label": "Descriptive summary statistics across groups for a categorical variable, based on subject occurrence",
      "id": "Mth_00_1",
      "operations": [
        {
          "name": "n",
          "label": "n",
          "id": "Mth_00_1_01_n",
          "order": 1,
          "resultPattern": "(N=XX)"
        }
      ]
    },
    {
      "name": "Summary by group of a categorical variable",
      "description": "Descriptive summary statistics across groups for a categorical variable, based on subject occurrence",
      "label": "Grouped summary of categorical variable",
      "id": "Mth_03",
      "operations": [
        {
          "name": "n",
          "label": "n",
          "id": "Mth_03_01_n",
          "order": 1,
          "resultPattern": "XX"
        },
        {
          "name": "%",
          "label": "%",
          "id": "Mth_03_02_%",
          "order": 2,
          "referencedOperationRelationships": [
            {
              "id": "Mth_03_pct_NUM",
              "referencedOperationRole": {
                "controlledTerm": "NUMERATOR"
              },
              "operationId": "Mth_03_01_n",
              "description": "The numerator for the calculation of the percentage."
            },
            {
              "id": "Mth_03_pct_DEN",
              "referencedOperationRole": {
                "controlledTerm": "DENOMINATOR"
              },
              "operationId": "Mth_00_1_01_n",
              "description": "The denominator for the calculation of the percentage."
            }
          ],
          "resultPattern": "(XX.X)"
        }
      ]
    },
    {
      "name": "Summary by group of a categorical variable",
      "description": "Descriptive summary statistics across groups for a categorical variable, based on subject occurrence",
      "label": "Grouped summary of categorical variable",
      "id": "Mth_03_1",
      "operations": [
        {
          "name": "Risk Difference %",
          "label": "Risk Difference %",
          "id": "Mth_03_1_01_Risk_Difference_%",
          "order": 1,
          "resultPattern": "XX.X"
        },
        {
          "name": "95% CI Low",
          "label": "95% CI Low",
          "id": "Mth_03_1_02_95%_CI_Low",
          "order": 2,
          "resultPattern": "XX.X"
        },
        {
          "name": "95% CI High",
          "label": "95% CI High",
          "id": "Mth_03_1_03_95%_CI_High",
          "order": 3,
          "resultPattern": "XX.X"
        }
      ]
    }
  ],
  "analyses": [
    {
      "name": "Summary of Subjects by Treatment",
      "id": "An_30",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "sponsorTermId": "TermEx01_01"
      },
      "methodId": "Mth_00_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "results": [
        {
          "operationId": "Mth_00_1_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "84",
          "formattedValue": "(N=84)"
        },
        {
          "operationId": "Mth_00_1_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "84",
          "formattedValue": "(N=84)"
        },
        {
          "operationId": "Mth_00_1_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "86",
          "formattedValue": "(N=86)"
        }
      ]
    },
    {
      "name": "Summary of subjects with any SAE by Treatment",
      "id": "An_31",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_07",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_31"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "1",
          "formattedValue": "1"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "2",
          "formattedValue": "2"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "(1.2)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "2.380952381",
          "formattedValue": "(2.4)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE, Xanomeline Low Dose vs Placebo",
      "id": "An_32",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_51",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "1.2"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-1.12892667",
          "formattedValue": "-1.1"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "3.509879051",
          "formattedValue": "3.5"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE, Xanomeline High Dose vs Placebo",
      "id": "An_32_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_52",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "2.380952381",
          "formattedValue": "2.4"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-0.879358897",
          "formattedValue": "-0.9"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "5.641263659",
          "formattedValue": "5.6"
        }
      ]
    },
    {
      "name": "Summary of subjects with any SAE that Results in Death by Treatment",
      "id": "An_33",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_08",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_33"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that Results in Death, Xanomeline Low Dose vs Placebo",
      "id": "An_34",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_53",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that Results in Death, Xanomeline High Dose vs Placebo",
      "id": "An_34_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_54",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Summary of subjects with any SAE that Is Life Threatening by Treatment",
      "id": "An_35",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_09",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_35"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "1",
          "formattedValue": "1"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "(1.2)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that Is Life Threatening, Xanomeline Low Dose vs Placebo",
      "id": "An_36",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_55",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that Is Life Threatening, Xanomeline High Dose vs Placebo",
      "id": "An_36_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_56",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "1.2"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-1.12892667",
          "formattedValue": "-1.1"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "3.509879051",
          "formattedValue": "3.5"
        }
      ]
    },
    {
      "name": "Summary of subjects with any SAE that Requires or Prolongs Hospitalization by Treatment",
      "id": "An_37",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_10",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_37"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "1",
          "formattedValue": "1"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "1",
          "formattedValue": "1"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "(1.2)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "(1.2)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that Requires or Prolongs Hospitalization, Xanomeline Low Dose vs Placebo",
      "id": "An_38",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_57",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "1.2"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-1.12892667",
          "formattedValue": "-1.1"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "3.509879051",
          "formattedValue": "3.5"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that Requires or Prolongs Hospitalization, Xanomeline High Dose vs Placebo",
      "id": "An_38_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_58",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "1.2"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-1.12892667",
          "formattedValue": "-1.1"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "3.509879051",
          "formattedValue": "3.5"
        }
      ]
    },
    {
      "name": "Summary of subjects with any SAE that Persist or Significant Disability / Incapacity by Treatment",
      "id": "An_39",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_11",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_39"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that involves Persist or Significant Disability / Incapacity, Xanomeline Low Dose vs Placebo",
      "id": "An_40",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_59",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that involves Persist or Significant Disability / Incapacity, Xanomeline High Dose vs Placebo",
      "id": "An_40_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_60",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Summary of subjects with any SAE that involves Congenital Anomaly or Birth Defect by Treatment",
      "id": "An_41",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_12",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_41"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that involves Congenital Anomaly or Birth Defect, Xanomeline Low Dose vs Placebo",
      "id": "An_42",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_61",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any SAE that involves Congenital Anomaly or Birth Defect, Xanomeline High Dose vs Placebo",
      "id": "An_42_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_62",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Summary of subjects with any Other SAE by Treatment",
      "id": "An_43",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_13",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_43"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any Other SAE, Xanomeline Low Dose vs Placebo ",
      "id": "An_44",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_63",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Comparison of subjects with any Other SAE, Xanomeline High Dose vs Placebo ",
      "id": "An_44_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_64",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Summary of subjects with AE leading to permanent discontinuation of study drug, by Treatment",
      "id": "An_45",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_14",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_45"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "1",
          "formattedValue": "1"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "2",
          "formattedValue": "2"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "1.1904761905",
          "formattedValue": "(1.2)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "2.3255813953",
          "formattedValue": "(2.3)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with AE leading to permanent discontinuation of study drug, Xanomeline Low Dose vs Placebo",
      "id": "An_46",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_65",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-1.135105205",
          "formattedValue": "-1.1"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-5.075455297",
          "formattedValue": "-5.1"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "2.8052448872",
          "formattedValue": "2.8"
        }
      ]
    },
    {
      "name": "Comparison of subjects with AE leading to permanent discontinuation of study drug, Xanomeline High Dose vs Placebo",
      "id": "An_46_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_66",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Summary of subjects with AE leading to dose modification of study drug, by Treatment",
      "id": "An_47",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_67",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_47"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "44",
          "formattedValue": "44"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "34",
          "formattedValue": "34"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "26",
          "formattedValue": "26"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "52.380952381",
          "formattedValue": "(52.4)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "40.476190476",
          "formattedValue": "(40.5)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "30.23255814",
          "formattedValue": "(30.2)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with AE leading to dose modification of study drug, Xanomeline Low Dose vs Placebo",
      "id": "An_48",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_68",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "22.148394241",
          "formattedValue": "22.1"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "7.7160104281",
          "formattedValue": "7.7"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "36.580778055",
          "formattedValue": "36.6"
        }
      ]
    },
    {
      "name": "Comparison of subjects with AE leading to dose modification of study drug, Xanomeline High Dose vs Placebo",
      "id": "An_48_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_69",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "10.243632337",
          "formattedValue": "10.2"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "-4.053388809",
          "formattedValue": "-4.1"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "24.540653483",
          "formattedValue": "24.5"
        }
      ]
    },
    {
      "name": "Summary of subjects with AE leading to dose modification of study drug, by Treatment and Action Taken",
      "id": "An_47_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_67",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        },
        {
          "order": 2,
          "groupingId": "AnlsGrouping_24_Aeacn",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_47"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "26",
          "formattedValue": "26"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "18",
          "formattedValue": "18"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "15",
          "formattedValue": "15"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "19",
          "formattedValue": "19"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "15",
          "formattedValue": "15"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "11",
          "formattedValue": "11"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "30.952380952",
          "formattedValue": "(31.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "21.428571429",
          "formattedValue": "(21.4)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "17.857142857",
          "formattedValue": "(17.9)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "22.619047619",
          "formattedValue": "(22.6)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "17.441860465",
          "formattedValue": "(17.4)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "12.790697674",
          "formattedValue": "(12.8)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with AE leading to dose modification of study drug by Action Taken, Xanomeline Low Dose vs Placebo",
      "id": "An_48_2",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_68",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        },
        {
          "order": 2,
          "groupingId": "AnlsGrouping_24_Aeacn",
          "resultsByGroup": true
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "13.510520487",
          "formattedValue": "13.5"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "8.6378737542",
          "formattedValue": "8.6"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "0.7800940873",
          "formattedValue": "0.8"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "-2.623906217",
          "formattedValue": "-2.6"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "26.240946887",
          "formattedValue": "26.2"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "19.899653726",
          "formattedValue": "19.9"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Comparison of subjects with AE leading to dose modification of study drug by Action Taken, Xanomeline High Dose vs Placebo",
      "id": "An_48_3",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_69",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        },
        {
          "order": 2,
          "groupingId": "AnlsGrouping_24_Aeacn",
          "resultsByGroup": true
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "0.415282392",
          "formattedValue": "0.4"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "9.8283499446",
          "formattedValue": "9.8"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "-11.04797844",
          "formattedValue": "-11.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "-1.567876818",
          "formattedValue": "-1.6"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_01"
            }
          ],
          "rawValue": "11.878543225",
          "formattedValue": "11.9"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_02"
            }
          ],
          "rawValue": "21.224576707",
          "formattedValue": "21.2"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_03"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_24_Aeacn",
              "groupId": "AnlsGrouping_24_Aeacn_04"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0.0"
        }
      ]
    },
    {
      "name": "Summary of subjects with Any AE by Treatment",
      "id": "An_49",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_70",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_49"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "77",
          "formattedValue": "77"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "79",
          "formattedValue": "79"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "69",
          "formattedValue": "69"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            }
          ],
          "rawValue": "91.666666667",
          "formattedValue": "(91.7)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            }
          ],
          "rawValue": "94.047619048",
          "formattedValue": "(94.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            }
          ],
          "rawValue": "80.23255814",
          "formattedValue": "(80.2)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with Any AE, Xanomeline Low Dose vs Placebo",
      "id": "An_50",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_71",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "11.434108527",
          "formattedValue": "11.4"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "1.1491146952",
          "formattedValue": "1.1"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "21.719102359",
          "formattedValue": "21.7"
        }
      ]
    },
    {
      "name": "Comparison of subjects with Any AE, Xanomeline High Dose vs Placebo",
      "id": "An_50_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_72",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "13.815060908",
          "formattedValue": "13.8"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "3.9942786179",
          "formattedValue": "4.0"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            }
          ],
          "rawValue": "23.635843198",
          "formattedValue": "23.6"
        }
      ]
    },
    {
      "name": "Summary of subjects with Any AE by Treatment and Severity/Intensity",
      "id": "An_49_1",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_70",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": true
        },
        {
          "order": 2,
          "groupingId": "AnlsGrouping_25_Aesev",
          "resultsByGroup": true
        }
      ],
      "referencedAnalysisOperations": [
        {
          "referencedOperationRelationshipId": "Mth_03_pct_NUM",
          "analysisId": "An_49"
        },
        {
          "referencedOperationRelationshipId": "Mth_03_pct_DEN",
          "analysisId": "An_30"
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "2",
          "formattedValue": "2"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "30",
          "formattedValue": "30"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "45",
          "formattedValue": "45"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "0"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "17",
          "formattedValue": "17"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "62",
          "formattedValue": "62"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "4",
          "formattedValue": "4"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "14",
          "formattedValue": "14"
        },
        {
          "operationId": "Mth_03_01_n",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "51",
          "formattedValue": "51"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "2.380952381",
          "formattedValue": "(2.4)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "35.714285714",
          "formattedValue": "(35.7)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_01"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "53.571428571",
          "formattedValue": "(53.6)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "0",
          "formattedValue": "(0.0)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "20.238095238",
          "formattedValue": "(20.2)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_02"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "73.80952381",
          "formattedValue": "(73.8)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "4.6511627907",
          "formattedValue": "(4.7)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "16.279069767",
          "formattedValue": "(16.3)"
        },
        {
          "operationId": "Mth_03_02_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An",
              "groupId": "AnlsGrouping_16_Trt01An_03"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "59.302325581",
          "formattedValue": "(59.3)"
        }
      ]
    },
    {
      "name": "Comparison of subjects with Any AE by Severity/Intensity, Xanomeline Low Dose vs Placebo",
      "id": "An_50_2",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_71",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        },
        {
          "order": 2,
          "groupingId": "AnlsGrouping_25_Aesev",
          "resultsByGroup": true
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "-2.27021041",
          "formattedValue": "-2.3"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "19.435215947",
          "formattedValue": "19.4"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "-5.73089701",
          "formattedValue": "-5.7"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "-7.787447987",
          "formattedValue": "-7.8"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "6.555760395",
          "formattedValue": "6.6"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "-20.61575502",
          "formattedValue": "-20.6"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "3.2470271676",
          "formattedValue": "3.2"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "32.314671499",
          "formattedValue": "32.3"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "9.1539609991",
          "formattedValue": "9.2"
        }
      ]
    },
    {
      "name": "Comparison of subjects with Any AE by Severity/Intensity, Xanomeline High Dose vs Placebo",
      "id": "An_50_3",
      "reason": {
        "controlledTerm": "SPECIFIED IN SAP"
      },
      "purpose": {
        "controlledTerm": "PRIMARY OUTCOME MEASURE"
      },
      "methodId": "Mth_03_1",
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ],
      "dataset": "ADAE",
      "variable": "USUBJID",
      "analysisSetId": "AnalysisSet_01",
      "dataSubsetId": "Dss_72",
      "orderedGroupings": [
        {
          "order": 1,
          "groupingId": "AnlsGrouping_16_Trt01An",
          "resultsByGroup": false
        },
        {
          "order": 2,
          "groupingId": "AnlsGrouping_25_Aesev",
          "resultsByGroup": true
        }
      ],
      "results": [
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "-4.651162791",
          "formattedValue": "-4.7"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "3.9590254707",
          "formattedValue": "4.0"
        },
        {
          "operationId": "Mth_03_1_01_Risk_Difference_%",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "14.507198228",
          "formattedValue": "14.5"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "-9.102036958",
          "formattedValue": "-9.1"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "-7.647199126",
          "formattedValue": "-7.6"
        },
        {
          "operationId": "Mth_03_1_02_95%_CI_Low",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "0.4994715975",
          "formattedValue": "0.5"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_01"
            }
          ],
          "rawValue": "-0.200288623",
          "formattedValue": "-0.2"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_02"
            }
          ],
          "rawValue": "15.565250067",
          "formattedValue": "15.6"
        },
        {
          "operationId": "Mth_03_1_03_95%_CI_High",
          "resultGroups": [
            {
              "groupingId": "AnlsGrouping_16_Trt01An"
            },
            {
              "groupingId": "AnlsGrouping_25_Aesev",
              "groupId": "AnlsGrouping_25_Aesev_03"
            }
          ],
          "rawValue": "28.514924859",
          "formattedValue": "28.5"
        }
      ]
    }
  ],
  "globalDisplaySections": [
    {
      "sectionType": "Header",
      "subSections": [
        {
          "id": "GlobalDisp_Header_01",
          "text": "CDISC - eTFL Portal"
        },
        {
          "id": "GlobalDisp_Header_02",
          "text": "Generated using TFL Designer (Community, v1.0)"
        },
        {
          "id": "GlobalDisp_Header_03",
          "text": "Page x of y"
        }
      ]
    }
  ],
  "outputs": [
    {
      "name": "Overview of Adverse Events",
      "id": "Out_04",
      "displays": [
        {
          "order": 1,
          "display": {
            "name": "=B3",
            "id": "Disp_04",
            "version": 1,
            "displayTitle": "=F3",
            "displaySections": [
              {
                "sectionType": "Header",
                "orderedSubSections": [
                  {
                    "order": 1,
                    "subSectionId": "GlobalDisp_Header_01"
                  },
                  {
                    "order": 2,
                    "subSectionId": "GlobalDisp_Header_02"
                  },
                  {
                    "order": 3,
                    "subSectionId": "GlobalDisp_Header_03"
                  }
                ]
              },
              {
                "sectionType": "Title",
                "orderedSubSections": [
                  {
                    "order": 1,
                    "subSection": {
                      "id": "Disp_04_Title_01",
                      "text": "FDA-AE-T06"
                    }
                  },
                  {
                    "order": 2,
                    "subSection": {
                      "id": "Disp_04_Title_02",
                      "text": "Overview of Adverse Events"
                    }
                  },
                  {
                    "order": 3,
                    "subSection": {
                      "id": "Disp_04_Title_03",
                      "text": "Safety Population"
                    }
                  }
                ]
              },
              {
                "sectionType": "Footnote",
                "orderedSubSections": [
                  {
                    "order": 1,
                    "subSection": {
                      "id": "Disp_04_Footnote_01",
                      "text": "Source: ADAE; Program name: fda-ae-t06.sas;"
                    }
                  },
                  {
                    "order": 2,
                    "subSection": {
                      "id": "Disp_04_Footnote_02",
                      "text": "Abbreviations: AE, adverse event; CI, confidence interval; N, number of subjects in treatment arm; n, number of subjects with at least one event; SAE, serious adverse event"
                    }
                  },
                  {
                    "order": 3,
                    "subSection": {
                      "id": "Disp_04_Footnote_03",
                      "text": "[1] Difference is shown between Xanomeline Low Dose vs. Placebo."
                    }
                  },
                  {
                    "order": 4,
                    "subSection": {
                      "id": "Disp_04_Footnote_04",
                      "text": "[2] Difference is shown between Xanomeline High Dose vs. Placebo."
                    }
                  },
                  {
                    "order": 5,
                    "subSection": {
                      "id": "Disp_04_Footnote_05",
                      "text": "[3] SAE is defined as any untoward medical occurrence that, at any dose that results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, results in persistent incapacity or substantial disruption of the ability to conduct normal life functions, or is a congenital anomaly or birth defect."
                    }
                  },
                  {
                    "order": 6,
                    "subSection": {
                      "id": "Disp_04_Footnote_06",
                      "text": "[4] Severity as assessed by the investigator"
                    }
                  }
                ]
              },
              {
                "sectionType": "Rowlabel Header",
                "orderedSubSections": [
                  {
                    "order": 1,
                    "subSection": {
                      "id": "Disp_04_RowlabelHeader_01",
                      "text": "Event"
                    }
                  }
                ]
              }
            ]
          }
        }
      ],
      "version": 1,
      "categoryIds": [
        "ANSET_01",
        "ANSET_01_ANINT_05"
      ]
    }
  ],
  "@type": "ReportingEvent"
}